Clinical Trials Directory

Trials / Completed

CompletedNCT02963142

A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia

A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia (S-CAP Study)

Status
Completed
Phase
Study type
Observational
Enrollment
103 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Severe community acquired pneumonia is common and associated with high mortality. Conventional microbiological diagnostics identify pathogens in approximately half of cases, which is inadequate for both clinical and epidemiological purposes. This study applies next-generation sequencing based metagenomic techniques to patients with extremely severe community acquired pneumonia, to investigate the microbiome of severe community acquired pneumonia and evaluate metagenomic approaches as diagnostic tools.

Conditions

Timeline

Start date
2016-12-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2016-11-15
Last updated
2019-05-02

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02963142. Inclusion in this directory is not an endorsement.